As a privately-owned, biopharmaceutical company, Ferring pioneers and delivers life-changing therapies that help people build families and live better lives. Our independence helps us cultivate an entrepreneurial spirit and long-term perspective that enables us to achieve growth and scale, while remaining agile and true to our ‘people first’ philosophy. Built on a 70-year plus commitment to science and research, Ferring is relentless in its pursuit of science that drives powerful discoveries and therapies to help people build families, stay healthy, and stand up to the world’s oldest enemy: disease. Our ambition is for our novel, first-in-class treatment for bladder cancer to become the new standard of care and backbone therapy for patients across the non-muscle invasive bladder cancer (NMIBC) disease spectrum. In 2024, our intravesical gene therapy achieved over 1,500 patients treated across the country at most major medical centers and community care centers. This exceptional first-year performance has made it among the top five best-selling gene therapies, and its uptake reflects a movement within the category toward innovative therapies and new hope for patients and their families. Our Uro-Oncology team is expanding with a variety of rewarding opportunities in commercial, medical affairs and technical operations. If you are energized by the prospect of bringing the benefits of cutting-edge science to meet the needs of patients, we may have the perfect role for you. The Director, Market Access Strategy & Marketing position is responsible for leading the development of Market Access marketing strategies and tactics for The Uro-Oncology Business Unit of Ferring Pharmaceuticals Uro-Oncology product including A) go-to-market recommendations, B) payer and trade channel strategy, C) market access value propositions and promotional tools, D) Specialty Pharmacy Execution E) Patient Services Support Strategy including Field Reimbursement F) internal communication resources. This is your opportunity to play an important role in making available to patients a novel therapy that has the potential to set a new benchmark for what’s possible in bladder cancer care. With Ferring, you will be joining a recognized leader, identified as one of “The World’s Most Innovative Companies” by Fast Company, and honored by Fortune with inclusion on its “Change the World List,” for addressing society’s unmet needs. Ferring US is also Great Places to Work® Certified, distinguishing it as one of the best companies to work for in the country.